Cytek Biosciences Inc. (CTKB)
| Bid | 2.68 |
| Market Cap | 464.99M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | -72.6 |
| Forward PE | 39.13 |
| Analyst | Buy |
| Ask | 3.64 |
| Volume | 375,619 |
| Avg. Volume (20D) | 869,054 |
| Open | 3.60 |
| Previous Close | 3.72 |
| Day's Range | 3.52 - 3.73 |
| 52-Week Range | 3.52 - 7.63 |
| Beta | 1.41 |
About CTKB
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full sp...
Analyst Forecast
According to 2 analyst ratings, the average rating for CTKB stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 92.84% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call TranscriptCytek Biosciences, Inc. (NASDAQ:CTKB ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Paul Goodson - IR Wenbin Jiang - CEO William McCombe - CFO Conference Call Par...
